Corneal Transplant Market Expected to Expand at a 5.6% CAGR, Reaching US$ 805.8 Million by 2034

The corneal transplant market was projected to attain US$ 444.3 million in 2023. It is likely to garner a 5.6% CAGR from 2024 to 2034, and by 2034, the market is expected to attain US$ 805.8 million.

Innovations in corneal transplant procedures, such as Descemet's Membrane Endothelial Keratoplasty (DMEK) and Descemet's Stripping Endothelial Keratoplasty (DSEK), have improved outcomes and reduced recovery times, making these surgeries more attractive to patients and practitioners.

Get an Exclusive Sample PDF Copy of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86150

Increased awareness about eye health and regular eye screening programs are helping in early detection of corneal diseases, thereby increasing the number of patients seeking treatment. Advances in diagnostic tools, imaging technologies, and surgical instruments are improving the precision and success rates of corneal transplant surgeries.

Key Findings of Market Report

• Research into stem cell therapies and regenerative medicine holds the potential to offer new treatments for corneal diseases, potentially reducing the need for donor corneas.
• Investing in the education and training of ophthalmologists and eye care professionals in advanced corneal transplant techniques can increase the number of qualified surgeons, thereby expanding the market.
• Chronic conditions such as diabetes can lead to complications like diabetic retinopathy, which increases the risk of corneal complications requiring transplants.
• Increased participation in sports and recreational activities contribute to a higher incidence of eye injuries, necessitating corneal transplants.

Market Trends for Corneal Transplant

• By procedure type, the endothelial keratoplasty segment is expected to augment the growth of the corneal transplant market.
• Endothelial Keratoplasty, particularly Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) and Descemet Membrane Endothelial Keratoplasty (DMEK), offers better visual outcomes compared to traditional penetrating keratoplasty.
• The precise replacement of the diseased endothelial layer results in quicker visual recovery and better visual acuity.
• On the basis of indication, the keratoconus segment is anticipated to accelerate the market growth.
• Keratoconus, a progressive thinning and bulging of the cornea, is becoming increasingly prevalent worldwide.
• The rise in incidence is driving the demand for corneal transplants as a definitive treatment for advanced cases.

Corneal Transplant Market: Key Players

The competitive landscape of the corneal transplant market involves several key players competing globally to provide innovative solutions for corneal diseases and disorders. The following companies are well known participants in the corneal transplant market:

• CryoLife Inc.
• ExaTech Inc.
• Köhler GmbH
• Lifeline Scientific Inc.
• LifeCell
• Medtronic
• DIOPTEX Medizinprodukte
• Presbia Plc
• KeraMed Inc.
• LinkoCare Life Sciences AB

Key Developments

• In 2022, Beijing Microkpro Medical Instrument Co. Ltd. achieved marketing approval from China's National Medical Products Administration (NMPA) for its innovative artificial cornea named Miok Keratoprosthesis.
• Marking a significant milestone, Miok Keratoprosthesis stands out as the inaugural artificial cornea entirely composed of 100% non-biological materials, eliminating the need for co-implantation of donor corneas.

Corneal Transplant Market Segmentation 

Procedure Type

• Penetrating Keratoplasty
• Endothelial Keratoplasty
• Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
• Corneal Graft
• Corneal Limbal Stem Cell Transplant
• Others (Deep Anterior Lamellar Keratoplasty, etc.)

Indication

• Fungal Corneal Ulcer
• Bullous Keratopathy
• Keratoconus
• Keratitis
• Others (Corneal Perforation, etc.)

End User

• Hospitals
• Eye Clinics
• Others (Research Institutes, etc.)

Region

• North America

• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Discover Key Insights – Visit Our Report Now! https://www.transparencymarketresearch.com/corneal-transplant-market.html

Explore Transparency Market Research Inc. Extensive Coverage in Healthcare Domain:

Bone Wax Market - The global bone wax market is estimated to rise at a CAGR of 3.3% from 2023 to 2031. Transparency Market Research projects that the overall sales revenue for bone wax is estimated to reach US$ 107.8 billion by the end of 2031.

Data Logger Market - The market for data loggers generated US$ 8 billion in revenue as of 2022. The market is predicted to reach US$ 12 billion in 2031. Between 2023 and 2031, the market is expected to register a CAGR of 5%.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com    

Email: sales@transparencymarketresearch.com

Follow Us: LinkedIn| Twitter| Blog | YouTube